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Pacific Island countries have a high burden of scabies and impetigo. Understanding of the
epidemiology of these diseases is needed to target public health interventions such as mass
drug administration (MDA). The aim of this study is to determine the prevalence of scabies
and impetigo in Solomon Islands as well as the relationship between them and their distribu-
tion. We conducted a prevalence study in 20 villages in Western Province in Solomon
Islands. All residents of the village were eligible to participate. Nurses conducted clinical
assessments including history features and skin examination. Diagnosis of scabies was
made using the 2020 International Alliance for the Control of Scabies diagnostic criteria.
Assessments were completed on 5239 participants across 20 villages. Overall scabies prev-
alence was 15.0% (95%CI 11.8–19.1). There was considerable variation by village with a
range of 3.3% to 42.6%. There was a higher prevalence of scabies in males (16.7%) than
females (13.5%, adjusted relative risk 1.2, 95%CI 1.1–1.4). Children aged under two years
had the highest prevalence (27%). Overall impetigo prevalence was 5.6% (95%CI 4.2–7.3),
ranging from 1.4% to 19% by village. The population attributable risk of impetigo associated
with scabies was 16.1% (95% CI 9.8–22.4). The prevalence of scabies in our study is com-
parable to previous studies in Solomon Islands, highlighting a persistent high burden of dis-
ease in the country, and the need for public health strategies for disease control.
Author summary
Scabies is a skin disease caused by infestation with the mite Sarcoptes scabiei var. hominis.
The mite burrows under the skin causing intense itch. Scabies lesions are commonly
infected with bacteria, causing impetigo. Pacific Island countries have a high burden of
scabies due to overcrowding, the tropical environment and limited access to treatment.
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We aimed to assess the prevalence of scabies and impetigo in 20 villages in Western Prov-
ince of Solomon Islands. We used the International Alliance for the Control of Scabies
2020 diagnostic criteria to diagnoses scabies. We found that 15% of the 5239 people sur-
veyed had scabies, and 5.6% had impetigo. While the prevalence of scabies was compara-
ble to other studies there were fewer cases of impetigo than observed previously. The
burden of disease was highest among children. Mass drug administration, where the
whole community is given treatment for a condition regardless of whether they have
symptoms of the disease, has been shown to reduce the prevalence of scabies. This study
supports the need for mass drug administration for scabies in Solomon Islands.
Introduction
Scabies is a skin condition caused by the parasitic mite Sarcoptes scabiei var. hominis. The mite
is primarily transmitted person-to-person by body contact. The mite burrows into the skin
causing intense itch and rash via a host immune-mediated response.[1] The host response and
scratching can lead to a break in the skin barrier which in turn can lead to secondary bacterial
skin infection, most frequently by Streptococcus pyogenes and Staphylococcus aureus. [2] Super-
ficial bacterial skin infection, known as impetigo, can lead to severe infections and serious
immune mediated complications of the internal organs, including the kidney and heart.[3,4]
Scabies is classified by the World Health Organization (WHO) as a neglected tropical disease,
with an estimated 455 million annual incident cases.[5] The disease has a high prevalence in many
low-resource tropical environments, particularly in Pacific Islands countries.[6] Scabies transmis-
sion occurs as a result of skin-to-skin contact and spreads easily in overcrowded living conditions.
Recent surveys in Solomon Islands have found all-age prevalence of scabies in the range 10
to 25% and impetigo 11 to 40%, but the relationship between the two diseases in these studies
is not consistent (Table 1). [7–11] For example, a study in 1984 observed a low prevalence of
scabies (1.3%) and a high prevalence of impetigo (43%), while a recent survey conducted in
school-age children found a high prevalence of both (54.3% and 32.1% respectively).[12,13]
The prevalence of scabies and impetigo may have been impacted by living conditions, environ-
mental and demographic factors.
Mass drug administration (MDA) is an effective control strategy for a number of neglected
tropical diseases, including scabies.[14] In high-prevalence settings, two doses of ivermectin-
based MDA has been shown to reduce the prevalence of scabies by around 90%.[7,15] The
consensus of experts at the WHO Informal Consultation on a Framework for Scabies Control
is that public health action such as MDA is recommended where community prevalence of
scabies is 10% or greater.[16]
The study was conducted as part of the Regimens of Ivermectin for Scabies Elimination
(RISE) trial (ACTRN12618001086257).[17] RISE is a cluster randomised, non-inferiority trial
of one versus two doses of ivermectin-based MDA in Solomon Islands. The aim of this study
was to determine the baseline prevalence of scabies and impetigo, the relationship between
them and their distribution. This study is one of the first to use the 2020 International Alliance
for the Control of Scabies (IACS) Criteria for diagnosis of scabies.[18]
Methods
Ethics statement
This trial was approved by the Solomon Islands Health Research and Ethics Review Board
(HRE005/18) and the Royal Children’s Hospital Human Research Ethics Committee,
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Melbourne, Australia (38099A). All participants provided written consent to participate. A
parent or guardian provided consent for people aged less than 18 years.
Setting
We conducted the study in Western Province in Solomon Islands, a country with over 900
islands and a population of approximately 700,000.[19] Solomon Islands is ranked 153 of 189
countries on the Human Development Index.[20] The scattered population presents chal-
lenges for health service delivery.[21] Western Province is one of nine provinces of Solomon
Islands and has a population of approximately 100,000.[19] It is located in the north-west of
the country, close to Papua New Guinea (Fig 1).
Twenty villages were included for the study, each with an estimated population between
200 and 400 people. Villages were selected in close consultation with the Western Provincial
Health Services. Criteria for village selection included separation from other villages, popula-
tion size, and a willingness to participate in the study. The separation of villages from others
was considered important for the RISE study so that there was not a high degree of admixing
between study villages that received MDA with other villages. Willingness to participate in the
study was determined by discussions with the Western Provincial Health Services and consul-
tation with village leaders. Based on information provided by village leaders, the estimated
combined population of the 20 villages was approximately 5,500 people. The sample size was
calculated for the RISE study, based on previous studies of scabies prevalence in Western Prov-
ince.[17] Three of the villages had a basic health clinic, while residents of other villages travel
for their medical care. The majority of village residents rely on subsistence agriculture for their
livelihood, with smaller numbers involved in logging and professional roles.
Study design
This study was a cross sectional assessment of scabies and impetigo prevalence in each village.
Village visits were carried out over an eight-week period between May and July 2019. The
study team spent between one and three days in each village. All residents present in the village
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on the days of the study team’s visit were eligible to participate. There were no exclusion crite-
ria for residents of the study villages to enrol in the study.
Clinical assessment
Four nurses from Western Province were trained in basic dermatologic clinical assessment
(skin examination and history taking), with particular emphasis on the signs and symptoms of
scabies as per the 2020 IACS Criteria, and clinical features of impetigo, and how to differenti-
ate these from other skin conditions using clinical criteria, without any specialised equipment.
[18] Nurses were taught to refer any suspected cases of crusted scabies for further assessment.
The training program included interactive tutorials run over a two-day period conducted by
three doctors experienced in scabies and impetigo diagnosis. The nurses then did supervised,
practical training at a primary school in Gizo, the largest population centre in the province.
[20] The same nurses conducted the clinical assessment in this study. As the training took
place approximately 8 months before village visits were conducted, a two-day refresher train-
ing program was conducted immediately before village visits commenced. Refresher training
consisted of further interactive tutorials, a written test and supervised clinical assessments at
the primary school.
Nurses assessed and recorded history and examination features. Participants were also
interviewed in regard to history of itch and the presence of itch or typical scabies rash in their
household or close contacts. Participants were shown photos of typical scabies rash to help
them recognise this pattern among their close contacts. Guardians provided history for infants
and young children.
Examination of the skin was limited to easily-exposed body areas (head and neck, hands
and arms, legs and feet). A limited examination was deemed appropriate as more widespread
examination was not practical in a field setting and examination of hands, feet and lower legs
Fig 1. Study area in Western Province, Solomon Islands. (The maps in this figure was drawn by Hilary Bruce at Murdoch Children’s Research Institute and adapted by
the authors of the manuscript. The source that was used to create the map is freevectormaps.com, https://freevectormaps.com/solomon-islands/SB-EPS-02-0001. The
authors understand and agree to the terms of the Creative Commons Attribution License).
https://doi.org/10.1371/journal.pntd.0009142.g001
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has been shown to detect close to 90% of cases compared to full body examination.[22] Nurses
did not examine the breasts, groin or genitals. Examination of children aged less than two
years included the trunk, as distribution of scabies may be more widespread in this age group.
[18,23]
For each participant, a nurse checked for the presence of scabetic lesions and recorded if
these were of typical or atypical appearance for scabies. They also checked for the presence of
infected skin lesions (impetigo). Severity of both scabies and impetigo were defined by the
number of lesions (very mild 1–2 lesions, mild 3–10 lesions, moderate 11–50 lesions, severe
>50 lesions). All data were entered directly into a database using Android devices in the field.
Study data were collected and managed using REDCap electronic data capture tools hosted at
Murdoch Children’s Research Institute.[24,25] REDCap is a secure, web-based software plat-
form designed to support data capture for research studies.
Impetigo was defined as papular, pustular or ulcerative lesions surrounded by erythema, or
with crusts, pus or bullae.[26] Severe infections including abscesses, ulcers, cellulitis and
crusted scabies were also recorded. Abscesses, cellulitis and secondarily infected scabies lesions
were classified as impetigo for data analysis.
Statistical analysis
Using the data from skin examinations and history features recorded by the nurses, we made a
scabies diagnosis for each individual according to the IACS criteria. When calculating the
prevalence of scabies, we defined scabies as per the 2020 IACS Criteria subcategories B3 (clini-
cal scabies), C1 and C2 (suspected scabies), which utilise both history and clinical features.[18]
We calculated the prevalence of scabies and impetigo overall, as well as for demographic
groups. We analysed scabies and impetigo prevalence across ten age groups to provide detailed
information of scabies and impetigo prevalence. We then used three broader age groups
(infants [under 2 years], children [2 to 14 years], and adults [15 years and above]) for further
analysis of diagnostic criteria’. A generalised linear model with a log link and binomial distri-
bution was used to model scabies and impetigo, adjusted for clustering by village. This model
was used to calculate confidence intervals (CI) for scabies and impetigo prevalence and
adjusted relative risk (ARR) for each category. The age group of those aged 50–59 years was
used as the reference group for calculating ARR for scabies and impetigo. We calculated popu-
lation attributable risk as a measure of the effect on population incidence of impetigo if scabies
was eliminated. We also calculated the Pearson correlation coefficient of scabies and impetigo
prevalence by village. All data analysis was performed using Stata (version 14.2, StataCorp,
College Station, TX, USA).
Results
We enrolled 5,239 participants, representing more than 95% of the estimated population of
the study villages (Tables 2 and S1). The enrolled population had comparable age and sex
structure to the overall population of Western Province in the 2009 national census but there
were some differences (S1 Fig).[27] There was a higher proportion of people aged less than 15
years in the study sample compared to the census (48% vs. 40%), and a higher proportion of
females (52.7% vs. 47.9%); in particular there were fewer males aged 20–39 years in the study.
Enrolment per village ranged from 109 to 443 participants (S2 Table). Enrolment in some vil-
lages was higher than the estimated population because of visitors who were staying in the
study village at the time.
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Scabies prevalence
There were 787 participants who met the diagnostic criteria for scabies (prevalence 15%, 95%
CI 11.8–19.1). The prevalence was higher in males than females (16.7% vs. 13.5%, ARR 1.2,
95%CI 1.1–1.4) and in children aged less than 2 years (27%, ARR 3.1, 95%CI 2.2–4.3 compared
to those aged 50 to 59 years, Table 2).
Scabies prevalence varied by village (Fig 2 and S2 Table). The median village prevalence
was 12.5% (IQR 8.9 to 20.0) with a range of 3.3% to 42.6%. The prevalence was higher than the
survey median in all villages on the island of Kolombangara (villages E, F, J, T) with median
25.7% and range 19.5 to 42.6%.
Overall, 51% of participants with scabies had very mild or mild disease (<10 lesions); and
15.3% had severe disease (>50 lesions, Table 3). No cases of crusted scabies were recorded.
Among participants with scabies, participants aged less than 2 years had the highest propor-
tion of moderate or severe scabies (71.8%, 95%CI 59.9–81.9), twice that of those aged 15 years
and above (35.8%, 95%CI 41.6). Nearly all participants diagnosed with scabies had lesions on
their upper limbs (96.2%), while 44.7% had scabies lesions on their lower limbs (Table 4).
Scabies diagnosis by 2020 IACS criteria
Of those with scabies, 439 (55.8%) had clinical scabies (subcategory B3) and 348 (44.2%) had
suspected scabies (subcategories C1: 26% and C2: 18.2%,) according to the 2020 IACS Criteria
classifications (Table 4). Among participants with scabies aged less than 2 years, 66.2% were in
subcategory B3, while among those aged 2 to 14 years 61.5% were in B3 and 45.1% in partici-
pants aged 15 years and older. The subcategorization between males and females was similar.
There were 503 participants (9.6%) with documented skin lesions on examination (148 with
typical scabies lesions, 355 with atypical scabies lesions) that did not meet the 2020 IACS crite-
ria for scabies diagnosis due to a lack of history features (presence of itch or positive contact
history).
Table 2. Prevalence of scabies and impetigo adjusted for village clustering.
Study sample Scabies Impetigo
N (%) n % (95%CI) ARR n % (95%CI) ARR
Sex
Female 2762 (52.7) 374 13.5 (0.6–17.2) Ref 131 4.7 (3.4–6.5) Ref
Male 2477 (47.3) 413 16.7 (13.0–21.4) 1.2 (1.1–1.4) 160 6.5 (5.0–8.4) 1.4 (1.1–1.7)
Age (years)
0–1 263 (5.0) 71 27.0 (21.1–34.5) 3.1 (2.2–4.3) 18 6.8 (4.0–11.7) 5.9 (1.8–19.5)
2–4 542 (10.3) 122 22.5 (17.1–29.7) 2.6 (1.7–4.0) 60 11.1 (7.2–17.0) 9.5 (2.9–30.5)
5–9 904 (17.3) 162 17.9 (13.4–23.9) 2.0 (1.2–3.4) 81 9.0 (6.2–13.0) 7.7 (3.0–19.9)
10–14 806 (15.4) 139 17.2 (12.8–23.2) 2.0 (1.3–2.9) 62 7.7 (5.6–10.6) 6.6 (2.4–17.7)
15–19 383 (7.3) 40 10.4 (7.1–15.3) 1.2 (0.8–1.8) 20 5.2 (3.6–7.7) 4.5 (1.3–15.7)
20–29 609 (11.6) 69 11.3 (7.8–16.5) 1.3 (0.9–1.8) 13 2.1 (1.2–3.8) 1.8 (0.5–6.7)
30–39 608 (11.6) 72 11.8 (8.5–16.5) 1.4 (0.9–2.0) 14 2.3 (1.5–3.6) 2.0 (0.6–6.2)
40–49 446 (8.5) 43 9.6 (6.3–14.7) 1.1 (0.7–1.8) 11 2.5 (1.5–4.1) 2.1 (0.7–6.1)
50–59 342 (6.5) 30 8.8 (5.5–14.0) Ref 4 1.2 (0.4–3.3) Ref
60+ 336 (6.4) 39 11.6 (7.2–18.8) 1.3 (0.8–2.2) 8 2.4 (1.0–5.5) 2.0 (0.6–6.9)
Total 5239 787 15.0 (11.8–19.1) 291 5.6 (4.2–7.3)
(CI: confidence interval; ARR: relative risk)
https://doi.org/10.1371/journal.pntd.0009142.t002
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On history, 23.9% of all participants reported itch. This was significantly higher in participants
with scabies (83.8%) than in those without scabies (12.5%, ARR 7.3, 95%CI 6.7–7.9). Overall prev-
alence of itch was similar across ages and by sex. Overall, 29.1% had a positive contact history.
This was higher in those with scabies (84.2%) compared to those without scabies (19.3%, ARR 4.4,
95%CI 4.1–4.7). Children under the age of two years were most likely to have positive contact his-
tory (33.5%) although the differences across age groups were not significant. The most sensitive
contact history feature was reporting a household contact with itch (72.9% of participants with
scabies). The least sensitive contact history feature was reporting a close contact with typical sca-
bies lesions (41% of participants with scabies). The contact history from close contacts reported in
children was similar to adults despite children having many close contacts in school.
Impetigo prevalence
Impetigo was diagnosed in 291 participants (5.6%, 95%CI 4.2–7.3). Prevalence was higher
among males (6.5% vs. 4.7% in females, ARR 1.4, 95%CI 1.1–1.7), and highest among children
aged 2 to 4 years (11.1%, ARR 9.5, 95%CI 2.9–30.5 compared to those aged 50–59 years,
Table 2). Among participants with impetigo, the majority had very mild disease (�2 lesions,
67.4%, Table 3). There were 12 participants (4.1%) with moderate to severe impetigo (>11
lesions), all aged less than 15 years, and half of them aged between 1 and 3 years.
When analysed by village, the median village impetigo prevalence was 5.1% (IQR 2.6 to 6.8,
range 1.4% to 19%). Unlike scabies, there was no distinct pattern in the geographical distribu-
tion of impetigo (Fig 3).
Fig 2. Geographical distribution of scabies in Western Province, Solomon Islands. (The maps in this figure was drawn by
Hilary Bruce at Murdoch Children’s Research Institute and adapted by the authors of the manuscript. The source that was used to
create the map is freevectormaps.com, https://freevectormaps.com/solomon-islands/SB-EPS-02-0001. The authors understand
and agree to the terms of the Creative Commons Attribution License).
https://doi.org/10.1371/journal.pntd.0009142.g002
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Association between scabies and impetigo
Of the participants with scabies, 81 of 787 (10.3%) had impetigo, a higher proportion than par-
ticipants without scabies (210 of 4452, 4.6%; RR 2.2, 95%CI 1.8–2.7). The population attribut-
able risk of impetigo associated with scabies was 16.1% (95%CI 9.8–22.4). The Pearson
correlation coefficient of the relationship between scabies and impetigo by village was 0.28
(P = 0.24), indicating a weak positive relationship that was not statistically significant (S2 Fig).
Discussion
We observed a very high prevalence of scabies (15.0%) and a moderately high prevalence of
impetigo (5.6%) in our study of over 5,000 participants of all ages in Solomon Islands. Young
children were especially affected by both conditions. These findings highlight the ongoing
high burden of scabies in the country and provide further impetus for public health action to
curb the impact of the disease.
The epidemiology of scabies has been studied in three of the nine provinces of Solomon
Islands (Table 1). With the exception of an early 1984 study, all studies observed a high preva-
lence of scabies. Our findings were comparable to a 2014 study in Western Province (preva-
lence 19.2%)[10] Our study included three of the 10 villages sampled in the 2014 study.
While still considered to be a moderately high prevalence of impetigo, the prevalence we
observed (5.6%) was lower than the 2014 study (32.7%) and other studies in Solomon Islands
(prevalence range 11.2% - 43%). The lower prevalence may reflect a real change, possibly due
to social, environmental factors and health care system factors. Our survey was conducted at
the beginning of the dry season, while the 2014 survey was conducted during the wet season,
when bacterial skin infections are more likely to occur.[10,28] It may also be that our study
under-diagnosed impetigo. Clinical assessments in our study were made by nurses who had
Table 3. Diagnosis and severity of scabies and impetigo.
Total Age Sex
N (%) <2 years n (%) 2–14 years n (%) � 15 years n (%) Male n (%) Female n (%)
Scabies
Prevalence 787 (15.0) 71 (27.0) 423 (18.8) 293 (10.8) 413 (16.7) 374 (13.5)
2020 IACS Category
B3: Typical lesions in a typical distribution and 2 history features 439 (55.8) 47 (66.2) 260 (61.5) 132 (45.1) 233 (56.4) 206 (55.1)
C1: Typical lesions in a typical distribution and 1 history feature 205 (26.0) 21 (29.6) 114 (27.0) 70 (23.9) 115 (27.8) 90 (24.1)
C2: Atypical lesions or atypical distribution and 2 history features 143 (18.2) 3 (4.2) 49 (11.6) 91 (31.1) 65 (15.7) 78 (20.9)
Severity
Very mild (1–2 lesions) 37 (4.7) 0 11 (2.6) 26 (8.9) 15 (3.6) 22 (5.9)
Mild (3–10 lesions) 364 (46.3) 20 (28.2) 182 (43.0) 162 (55.3) 182 (44.1) 182 (48.7)
Moderate (11–50 lesions) 266 (33.8) 28 (39.4) 162 (38.3) 76 (25.9) 149 (36.1) 117 (31.3)
Severe (>50 lesions) 120 (15.3) 23 (32.4) 68 (16.1) 29 (9.9) 67 (16.2) 53 (14.2)
Impetigo
Prevalence 291 (5.6) 18 (6.8) 203 (9.0) 70 (2.6) 160 (6.5) 131 (4.7)
Severity
Very mild (1–2 lesions) 196 (67.4) 4 (22.2) 136 (67.0) 56 (80.0) 99 (61.9) 97 (74.0)
Mild (3–10 lesions) 79 (27.1) 12 (66.7) 55 (27.1) 12 (17.1) 51 (31.9) 28 (21.4)
Moderate (11–50 lesions) 9 (3.1) 2 (11.1) 7 (3.4) 0 5 (3.1) 4 (3.1)
Severe (>50 lesions) 3 (1.0) 0 3 (1.5) 0 3 (1.9) 0
Unknown 4 (1.4) 0 2 (1.0) 2 (2.9) 2 (1.3) 2 (1.5)
Total 5239 263 2252 2724 2477 2762
https://doi.org/10.1371/journal.pntd.0009142.t003
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completed a brief training package. In a study of the accuracy of this approach, nurses had a
sensitivity of 53% for diagnosis of impetigo compared to expert physicians, and were particu-
larly likely to miss mild disease.[20] The diagnosis of scabies had a slightly similar sensitivity of
55%. Given these findings, we ran further training for nurses prior to starting our study, par-
ticularly focussing on detecting mild cases. However, under-diagnosis may still have occurred.
There was substantial variation between villages in prevalence of scabies (range 3 to 43%)
and impetigo (1 to 19%). We observed a weak relationship between scabies and impetigo prev-
alence by village which was not statistically significant. The variation may be partly explained
by differences in geography and climate. For example, on Kolombangara island, which experi-
ences a high amount of rainfall and cooler temperatures than other islands, all villages had a
scabies prevalence of over 19%. While some studies have shown a positive correlation between
rainfall or cold weather and the incidence of scabies, others have shown no increase in scabies
prevalence in the wet season.[28–30] While it is known that crowding can influence scabies
prevalence and transmission we did not collect information on living conditions.[1] Despite
the pathophysiological link between scabies and impetigo, a 2015 systematic review of scabies
and impetigo prevalence worldwide did not find a strong correlation between the prevalence
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Head 43 (0.8) 36 (4.6) 7 (0.2) 13 (4.9) 23 (1.0) 7 (0.3) 24 (1.0) 19 (0.7)
Trunk� 43 (0.8) 38 (4.8) 5 (0.1) 8 (3.0) 29 (1.3) 6 (0.2) 19 (0.8) 24 (0.9)
Lesions in any location 1289
(24.6)











Any positive contact history 1522
(29.1)
663 (84.2) 859 (19.3) 88 (33.5) 664 (29.5) 770 (28.3) 731
(29.5)
791 (28.6)
Household contact w/itch 1070
(20.4)
574 (72.9) 496 (11.1) 68 (25.9) 486 (21.6) 516 (18.9) 520
(21.0)
550 (19.9)
Close contact w/itch 687
(13.1)







493 (62.6) 389 (8.7) 59 (22.4) 399 (17.7) 424 (15.6) 421
(17.0)
461 (16.7)




323 (41.0) 469 (10.5) 48 (18.3) 351 (15.6) 393 (14.4) 370
(14.9)
422 (15.3)
Total 5239 787 4452 263 2252 2724 2477 2762
� Trunk not routinely examined in participants�2 years old
https://doi.org/10.1371/journal.pntd.0009142.t004
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of the two diseases across populations.[6] The relationship between the two diseases may differ
over time and by place, due to local factors that are not well understood. The differences in
observed prevalence may be explained by natural fluctuation, differences in the diagnostic
methods or other, unidentified factors.[31]
This study had several limitations. First, the history components of the clinical assessment
may have been under-reported due to normalisation of itch and skin lesions in communities.
[32] In a setting where one in six people have scabies, it is likely that most people would have a
close contact with scabies, however less than 30% reported a positive contact history. Second,
while there were advantages to using trained nurses to conduct the clinical assessment, this
may have resulted in reduced diagnostic accuracy of both scabies and impetigo compared to
specialists. Mild cases may have been under-diagnosed, as found previously.[20] Third, the
study population represents approximately 5% of the population of Western Province. While
there was a high level of participation in the study villages there are some differences in the age
and sex of the study population compared to the population of Western Province. There is a
degree of bias in the selection of study villages as they were required to be a certain size for the
RISE study and therefore did not capture very small villages or urban populations.
There is an ongoing, high prevalence of scabies and impetigo in Solomon Islands. Further
studies in other provinces and urban settings would help to understand the national burden of
the disease. The methodology used in this study may be appropriate for future scabies and
impetigo prevalence studies. The limited skin examination is appropriate for a field setting.
Diagnosis of scabies according to the 2020 IACS Criteria allows direct comparison between
Fig 3. Geographical distribution of impetigo in Western Province, Solomon Islands. (The maps in this figure was drawn by
Hilary Bruce at Murdoch Children’s Research Institute and adapted by the authors of the manuscript. The source that was used to
create the map is freevectormaps.com, https://freevectormaps.com/solomon-islands/SB-EPS-02-0001. The authors understand
and agree to the terms of the Creative Commons Attribution License).
https://doi.org/10.1371/journal.pntd.0009142.g003
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the results of this study and others that have used the same diagnostic criteria. Public health
strategies are needed, with parallel operational research to evaluate the effectiveness of these
strategies. Studies, such as the RISE trial, into community control of scabies will help to inform
policy to eliminate scabies as a public health problem.
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